Citations 0
January 2001

Retinal Vasoproliferative Tumors: A Conservative Approach

Author Affiliations

Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001

Arch Ophthalmol. 2001;119(1):145. doi:

I read with great interest the clinicopathologic report by Irvine et al.1 This report clearly and rightly favors the more conservative approach of local transcleral resection of peripheral retinal vasoproliferative masses, which cannot be positively differentiated from malignant melanoma of the choroid. This not only saves the patient an unnecessary enucleation but also spares the surgeon from the embarrassment of removing an eye that is noncancerous. I believe that in cases with no evidence of preoperative choroidal involvement, it is better not to implant the ruthenium 106 plaque until the results of the histopathological examination are available. This will save the patient from the second surgical procedure of removing the plaque, which may be unnecessary in the first place. If, however, the histopathological report confirms a malignant melanoma, a ruthenium 106 plaque should be applied.

First Page Preview View Large
First page PDF preview
First page PDF preview